Back to Search
Start Over
Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with chronic heart failure: model development and data analysis.
- Source :
-
Cost Effectiveness & Resource Allocation . 11/6/2023, Vol. 21 Issue 1, p1-16. 16p. - Publication Year :
- 2023
-
Abstract
- Background: In recent years, numerous guidelines and expert consensus have recommended the inclusion of digital technologies and products in cardiac rehabilitation. Digital therapeutics (DTx) is an evidence-based medicine that uses digital means for data collection and monitoring of indicators to control and optimize the treatment, management, and prevention of disease. Objective: This study collected and reviewed real-world data and built a model using health economics assessment methods to analyze the potential cost-effectiveness of DTx applied to home-based cardiac rehabilitation for patients with chronic heart failure. From the perspective of medical and health decision-makers, the economic value of DTx is evaluated prospectively to provide the basis and reference for the application decision and promotion of DTx. Methods: Markov models were constructed to simulate the outcomes of DTx for home-based cardiac rehabilitation (DT group) compared to conventional home-based cardiac rehabilitation (CH group) in patients with chronic heart failure. The model input parameters were clinical indicators and cost data. Outcome indicators were quality-adjusted life years (QALYs) and incremental cost-effectiveness ratios (ICERs). The robustness of the evaluation methods and results was tested using sensitivity analyses. Clinical indicators, cost data, and health utility values were obtained from real-world data, including clinical study data, published literature, and public website information. Results: The Markov model simulated a time span of 10 years, with a cycle set at one month, for 120 cycles. The results showed that the per capita cost of the CH group was 38,442.11 CNY/year, with a QALY of 0.7196 per person per year. The per capita cost of the DT group was 42,300.26 CNY/year, with a QALY of 0.81687 per person per year. The ICER per person was 39,663.5 CNY/QALY each year, which was below the willingness-to-pay threshold of 85,698 CNY (China's GDP per capita in 2022). Conclusions: DTx for home-based cardiac rehabilitation is an extremely cost-effective rehabilitation option compared with conventional home-based cardiac rehabilitation. DTx for home-based cardiac rehabilitation is potentially valuable from the perspective of healthcare decision-makers. [ABSTRACT FROM AUTHOR]
- Subjects :
- *MEDICAL rehabilitation
*PROFESSIONAL practice
*COMPUTERS
*KEY performance indicators (Management)
*HOME rehabilitation
*DIGITAL technology
*MEDICAL care costs
*PATIENTS
*EVIDENCE-based medicine
*SIMULATION methods in education
*COMPARATIVE studies
*MEDICAL care use
*COST effectiveness
*CARDIAC rehabilitation
*AUTOMATIC data collection systems
*DESCRIPTIVE statistics
*CLINICAL medicine
*QUALITY assurance
*RESEARCH funding
*STATISTICAL models
*DATA analysis
*HEART failure
*QUALITY-adjusted life years
Subjects
Details
- Language :
- English
- ISSN :
- 14787547
- Volume :
- 21
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Cost Effectiveness & Resource Allocation
- Publication Type :
- Academic Journal
- Accession number :
- 173456053
- Full Text :
- https://doi.org/10.1186/s12962-023-00489-x